Confounded Interest
Contributor since: 2017
Latest Articles
J.P. Morgan's Analyst Can Take A Hike - GE Is A Long-Term Buy
The Dr. Jekyll And Mr. Hyde Portfolios: Hyde Edition - Positions #21 - 26
Time To Clean House In My Portfolio - 4 Sales With 2 More Facing The Executioner
Nike: Know When To Sell A Winner
I Kicked Amazon To The Curb For Alibaba On Valentine's Day
PG&E: Bad Location, Huge Liability, Regulators Piling On, And A 45% Decline. So, Buy It?
Corning: Market Turmoil Creates A Perfect Entry Point For This Long Runway Growth Company
Trinity Industries: Infrastructure And Rail Cars, A Heavy Industrial Play Splits In 2
Coca-Cola: Yes It Is Still Overvalued, But I Really Don't Care
General Mills: It's Boring, It's Old And It's Fairly Valued - Just What I Need More Of In 2018
Genocea Biosciences: 200% Dilution, Hopelessness And Anger. Why Am I Still Holding? GEN-009 And ATLAS
Ascendis Pharma: The Rebound Purchase To End My Versartis Nightmare
Halozyme Therapeutics: ENHANZE Alone Is Well Worth A Huge Bet On This Underfollowed Biotech
Cheniere Energy: Pure Play On Energy's Future - But The Company's Structure Is Ugly
Vestas Wind Systems: Short-Term Troubles Provide A Fantastic Opportunity For Long-Term Investors
Nutrien, Inc.: Overpopulation And Obesity - Nutrien Set To Thrive In The New World Of Agriculture
Southern Company: Total Return Of 10% Per Year Is Possible With One Of The Industry's Problem Children
Wal-Mart Is Massively Overvalued, But Is That OK For 2018?
Diageo: If You're Going To Sin, Do It In Style
General Electric: The Crazy Ex-Girlfriend I'm Now About To Marry
Corning: If The World Of The Future Is Made Of Glass, This Company Looks Shatterproof
ViaSat: Strike While The Iron Is... Still Room Temperature?
Philip Morris International: IQOS - Confessions Of An Addict
Marathon Oil: A Fantastic Company With A Fantastic Price That I May Need To Sell
Aimmune Therapeutics - Desensitize Yourself For A Good Bet!
Heading Into 2018 - With Cautious Optimism